Search Results - "Reader CS"

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.

Authors: Brooke GN Leach DA Culley RL et al.

Source: Oncogene [Oncogene] 2026 Mar; Vol. 45 (8), pp. 757-773. Date of Electronic Publication: 2026 Feb 06.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growth.

Authors: Gasparri, Anna Maria Pocaterra, Arianna Colombo, Barbara et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 3/8/2025, Vol. 44 Issue 1, p1-21. 21p.

Research on Chinese Machine Reading Comprehension Model Based on Enhanced Semantic Information Capture.

Authors: Wang, Yanfeng Ma, Ning

Source: Journal of Information Processing Systems; Feb2026, Vol. 22 Issue 1, p21-33, 13p

Multi-omics analysis reveals cell adhesion molecules as key regulators of immune cell infiltration and adverse outcomes and in vitro validation of CLDN16 in pancreatic adenocarcinoma.

Authors: Zhuo Z Luo J Liang G et al.

Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2025 Dec 18; Vol. 83 (1). Date of Electronic Publication: 2025 Dec 18.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE

The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.

Authors: Reader CS Vallath S Steele CW et al.

Source: The Journal of pathology [J Pathol] 2019 Nov; Vol. 249 (3), pp. 332-342. Date of Electronic Publication: 2019 Jul 30.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE

Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation.

Authors: Zhang C Liu J Gu T et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jun; Vol. 211 (3), pp. 637-648. Date of Electronic Publication: 2025 Mar 06.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv.

Authors: Phanthaphol, Nattaporn Somboonpatarakun, Chalermchai Suwanchiwasiri, Kwanpirom et al.

Source: Journal of Translational Medicine. 4/16/2025, Vol. 23 Issue 1, p1-17. 17p.

(−1)-form symmetries from M-theory and SymTFTs.

Authors: Najjar, Marwan Santilli, Leonardo Wang, Yi-Nan

Source: Journal of High Energy Physics. Mar2025, Vol. 2025 Issue 3, p1-95. 95p.

Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion.

Authors: Murray ER Menezes S Henry JC et al.

Source: Cell reports [Cell Rep] 2022 Jan 25; Vol. 38 (4), pp. 110227.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.

Authors: Quigley, Neil Gerard Steiger, Katja Hoberück, Sebastian et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Mar2022, Vol. 49 Issue 4, p1136-1147. 12p. 1 Color Photograph, 1 Black and White Photograph, 1 Diagram, 2 Charts, 1 Graph.

Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression.

Authors: Kemper, Marius Schiecke, Alina Maar, Hanna et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 6/26/2021, Vol. 40 Issue 1, p1-19. 19p.

Effects of a Bacterial Infection on Mitochondrial Function and Oxidative Stress in a Songbird.

Authors: Zhang, Yufeng Hill, Geoffrey E. Ge, Zhiyuan et al.

Source: Physiological & Biochemical Zoology. Mar/Apr2021, Vol. 94 Issue 2, p71-82. 12p. 2 Charts, 3 Graphs.

Integrin β5 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese population.

Authors: LIXING MA KANG SONG JINFENG ZANG

Source: Experimental & Therapeutic Medicine. Nov2023, Vol. 26 Issue 5, p1-12. 12p.

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.

Authors: Cai, Letong Li, Yuchen Tan, Jiaxiong et al.

Source: Journal of Hematology & Oncology. 9/5/2023, Vol. 16 Issue 1, p1-34. 34p.

Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy.

Authors: Tiancheng Zhang Youpei Lin Qiang Gao

Source: Cancer Biology & Medicine. Mar2023, Vol. 20 Issue 3, p181-195. 15p.

Exploring the interactions of integrins and CEACAM6 (Review).

Authors: Al-Khinji, Aisha¹ (AUTHOR) aalkhinji@qu.edu.qa

Source: Experimental & Therapeutic Medicine. Dec2025, Vol. 30 Issue 6, pN.PAG-N.PAG. 1p.

Progress and prospects for use of cellular immunotherapy in pancreatic cancer.

Authors: Tian, Jing Bai, Tiankai Zhang, Zhiyong et al.

Source: Journal of Cancer Research & Therapeutics. Dec2022, Vol. 18 Issue 7, p1867-1875. 9p.

The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma.

Authors: Badder LM Davies JA Meniel VS et al.

Source: British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1694-1706. Date of Electronic Publication: 2024 Oct 05.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Preclinical evaluation of ⁶⁸Ga- and ¹⁷⁷Lu-labeled integrin αvβ6-targeting radiotheranostic peptides.

Authors: Ganguly, Tanushree Bauer, Nadine Davis, Ryan A. et al.

Source: Journal of Nuclear Medicine. Oct2022, Vol. 63 Issue 10, p1-43. 43p.

Nasal allergen and methacholine provocation tests influence co‑expression patterns of TGF‑β/SMAD and MAPK signaling pathway genes in patients with asthma.

Authors: Plichta, Jacek Majos, Alicja Kuna, Piotr et al.

Source: Experimental & Therapeutic Medicine. Dec2024, Vol. 28 Issue 6, pN.PAG-N.PAG. 1p.